AR 231453 is primarily researched for its potential applications in the field of pharmacology and neuroscience. It is known to act as a selective agonist for certain cannabinoid receptors, which makes it a compound of interest in studying the endocannabinoid system. Researchers are exploring its use in understanding pain management, neuroprotection, and the regulation of appetite and mood. Additionally, AR 231453 may have implications in developing treatments for conditions like anxiety, depression, and neurodegenerative diseases. Its specific receptor activity also makes it a valuable tool in experimental studies aimed at uncovering the therapeutic potential of cannabinoid-based therapies.